{"id":"https://openalex.org/W2144264656","doi":"https://doi.org/10.1158/1078-0432.ccr-08-2980","title":"Insulin-Like Growth Factor-1 Receptor Inhibition Induces a Resistance Mechanism via the Epidermal Growth Factor Receptor/HER3/AKT Signaling Pathway: Rational Basis for Cotargeting Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor in Hepatocellular Carcinoma","display_name":"Insulin-Like Growth Factor-1 Receptor Inhibition Induces a Resistance Mechanism via the Epidermal Growth Factor Receptor/HER3/AKT Signaling Pathway: Rational Basis for Cotargeting Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor in Hepatocellular Carcinoma","alternate_titles":[],"publication_year":2009,"publication_date":"2009-08-31","ids":{"openalex":"https://openalex.org/W2144264656","doi":"https://doi.org/10.1158/1078-0432.ccr-08-2980","mag":"2144264656","pmid":"https://pubmed.ncbi.nlm.nih.gov/19706799"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-08-2980","doi":"https://doi.org/10.1158/1078-0432.ccr-08-2980","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-08-2980","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2144264656"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074178383","display_name":"Christ\u00e8le Desbois\u2010Mouthon","orcid":"https://orcid.org/0000-0002-0772-1711","observed_orcids":["https://orcid.org/0000-0002-0772-1711"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210102928","display_name":"H\u00f4pital Saint-Antoine","ror":"https://ror.org/01875pg84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210102928"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christ\u00e8le Desbois-Mouthon","raw_affiliation_strings":["Authors' Affiliations:\u20081UPMC Univ Paris 06; 2Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, UMR_S 938; and 3AP-HP, H\u00f4pital Saint-Antoine, Service d'H\u00e9patologie, Paris, France; and 4Sanofi-aventis, Vitry-sur-Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081UPMC Univ Paris 06; 2Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, UMR_S 938; and 3AP-HP, H\u00f4pital Saint-Antoine, Service d'H\u00e9patologie, Paris, France; and 4Sanofi-aventis, Vitry-sur-Seine, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210097159","https://openalex.org/I4210102928","https://openalex.org/I4405264447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027606829","display_name":"Aurore Baron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210102928","display_name":"H\u00f4pital Saint-Antoine","ror":"https://ror.org/01875pg84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210102928"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aurore Baron","raw_affiliation_strings":["Authors' Affiliations:\u20081UPMC Univ Paris 06; 2Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, UMR_S 938; and 3AP-HP, H\u00f4pital Saint-Antoine, Service d'H\u00e9patologie, Paris, France; and 4Sanofi-aventis, Vitry-sur-Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081UPMC Univ Paris 06; 2Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, UMR_S 938; and 3AP-HP, H\u00f4pital Saint-Antoine, Service d'H\u00e9patologie, Paris, France; and 4Sanofi-aventis, Vitry-sur-Seine, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210097159","https://openalex.org/I4210102928","https://openalex.org/I4405264447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038453103","display_name":"Marie-Jos\u00e9 Blivet-Van Eggelpo\u00ebl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210102928","display_name":"H\u00f4pital Saint-Antoine","ror":"https://ror.org/01875pg84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210102928"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marie-Jos\u00e9 Blivet-Van Eggelpo\u00ebl","raw_affiliation_strings":["Authors' Affiliations:\u20081UPMC Univ Paris 06; 2Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, UMR_S 938; and 3AP-HP, H\u00f4pital Saint-Antoine, Service d'H\u00e9patologie, Paris, France; and 4Sanofi-aventis, Vitry-sur-Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081UPMC Univ Paris 06; 2Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, UMR_S 938; and 3AP-HP, H\u00f4pital Saint-Antoine, Service d'H\u00e9patologie, Paris, France; and 4Sanofi-aventis, Vitry-sur-Seine, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210097159","https://openalex.org/I4210102928","https://openalex.org/I4405264447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043245662","display_name":"L\u00e6titia Fartoux","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210102928","display_name":"H\u00f4pital Saint-Antoine","ror":"https://ror.org/01875pg84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210102928"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Laetitia Fartoux","raw_affiliation_strings":["Authors' Affiliations:\u20081UPMC Univ Paris 06; 2Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, UMR_S 938; and 3AP-HP, H\u00f4pital Saint-Antoine, Service d'H\u00e9patologie, Paris, France; and 4Sanofi-aventis, Vitry-sur-Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081UPMC Univ Paris 06; 2Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, UMR_S 938; and 3AP-HP, H\u00f4pital Saint-Antoine, Service d'H\u00e9patologie, Paris, France; and 4Sanofi-aventis, Vitry-sur-Seine, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210097159","https://openalex.org/I4210102928","https://openalex.org/I4405264447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035564601","display_name":"Corinne Venot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210102928","display_name":"H\u00f4pital Saint-Antoine","ror":"https://ror.org/01875pg84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210102928"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Corinne Venot","raw_affiliation_strings":["Authors' Affiliations:\u20081UPMC Univ Paris 06; 2Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, UMR_S 938; and 3AP-HP, H\u00f4pital Saint-Antoine, Service d'H\u00e9patologie, Paris, France; and 4Sanofi-aventis, Vitry-sur-Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081UPMC Univ Paris 06; 2Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, UMR_S 938; and 3AP-HP, H\u00f4pital Saint-Antoine, Service d'H\u00e9patologie, Paris, France; and 4Sanofi-aventis, Vitry-sur-Seine, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210097159","https://openalex.org/I4210102928","https://openalex.org/I4405264447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001478887","display_name":"Friedhelm Bladt","orcid":"https://orcid.org/0009-0000-3482-2406","observed_orcids":["https://orcid.org/0009-0000-3482-2406"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210102928","display_name":"H\u00f4pital Saint-Antoine","ror":"https://ror.org/01875pg84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210102928"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Friedhelm Bladt","raw_affiliation_strings":["Authors' Affiliations:\u20081UPMC Univ Paris 06; 2Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, UMR_S 938; and 3AP-HP, H\u00f4pital Saint-Antoine, Service d'H\u00e9patologie, Paris, France; and 4Sanofi-aventis, Vitry-sur-Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081UPMC Univ Paris 06; 2Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, UMR_S 938; and 3AP-HP, H\u00f4pital Saint-Antoine, Service d'H\u00e9patologie, Paris, France; and 4Sanofi-aventis, Vitry-sur-Seine, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210097159","https://openalex.org/I4210102928","https://openalex.org/I4405264447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043299615","display_name":"Chantal Housset","orcid":"https://orcid.org/0000-0001-6469-0651","observed_orcids":["https://orcid.org/0000-0001-6469-0651"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210102928","display_name":"H\u00f4pital Saint-Antoine","ror":"https://ror.org/01875pg84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210102928"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Chantal Housset","raw_affiliation_strings":["Authors' Affiliations:\u20081UPMC Univ Paris 06; 2Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, UMR_S 938; and 3AP-HP, H\u00f4pital Saint-Antoine, Service d'H\u00e9patologie, Paris, France; and 4Sanofi-aventis, Vitry-sur-Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081UPMC Univ Paris 06; 2Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, UMR_S 938; and 3AP-HP, H\u00f4pital Saint-Antoine, Service d'H\u00e9patologie, Paris, France; and 4Sanofi-aventis, Vitry-sur-Seine, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210097159","https://openalex.org/I4210102928","https://openalex.org/I4405264447"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020985866","display_name":"Olivier Rosmorduc","orcid":"https://orcid.org/0009-0005-7878-8971","observed_orcids":["https://orcid.org/0009-0005-7878-8971","https://orcid.org/0000-0002-6695-3088"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210102928","display_name":"H\u00f4pital Saint-Antoine","ror":"https://ror.org/01875pg84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210102928"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Olivier Rosmorduc","raw_affiliation_strings":["Authors' Affiliations:\u20081UPMC Univ Paris 06; 2Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, UMR_S 938; and 3AP-HP, H\u00f4pital Saint-Antoine, Service d'H\u00e9patologie, Paris, France; and 4Sanofi-aventis, Vitry-sur-Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081UPMC Univ Paris 06; 2Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, UMR_S 938; and 3AP-HP, H\u00f4pital Saint-Antoine, Service d'H\u00e9patologie, Paris, France; and 4Sanofi-aventis, Vitry-sur-Seine, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210097159","https://openalex.org/I4210102928","https://openalex.org/I4405264447"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":10.2816,"has_fulltext":false,"cited_by_count":163,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.98834886,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"15","issue":"17","first_page":"5445","last_page":"5456"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9413999915122986,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9413999915122986,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.029200000688433647,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.013299999758601189,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/igf-1-receptor","display_name":"IGF-1 receptor","score":0.9350000023841858},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.890999972820282},{"id":"https://openalex.org/keywords/her3","display_name":"HER3","score":0.7319999933242798},{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.8949999809265137},{"id":"https://openalex.org/keywords/akt-signaling","display_name":"Akt signaling","score":0.8920000195503235},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.8360000252723694},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8399999737739563},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.890999972820282},{"id":"https://openalex.org/keywords/rapamycin","display_name":"rapamycin","score":0.8009999990463257},{"id":"https://openalex.org/keywords/hepatoma-cell-lines","display_name":"hepatoma cell lines","score":0.6539999842643738}],"concepts":[{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.7554938197135925},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.7302290201187134},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.6921709179878235},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.5909159183502197},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5726882219314575},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5715987086296082},{"id":"https://openalex.org/C26375932","wikidata":"https://www.wikidata.org/wiki/Q118226","display_name":"Growth factor receptor","level":3,"score":0.5614545345306396},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.5436363816261292},{"id":"https://openalex.org/C130287650","wikidata":"https://www.wikidata.org/wiki/Q17091190","display_name":"Growth factor receptor inhibitor","level":4,"score":0.5379868745803833},{"id":"https://openalex.org/C2780689927","wikidata":"https://www.wikidata.org/wiki/Q24766801","display_name":"Insulin-like growth factor","level":4,"score":0.5212391018867493},{"id":"https://openalex.org/C2776362946","wikidata":"https://www.wikidata.org/wiki/Q424374","display_name":"Epidermal growth factor","level":3,"score":0.5026841163635254},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5009827613830566},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.4837813079357147},{"id":"https://openalex.org/C2779314089","wikidata":"https://www.wikidata.org/wiki/Q18026830","display_name":"HCCS","level":3,"score":0.4399604797363281},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.42837095260620117},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.42009955644607544},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3669188618659973},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13994619250297546},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.08584770560264587}],"mesh":[{"descriptor_ui":"D000077156","descriptor_name":"Gefitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D017526","descriptor_name":"Receptor, IGF Type 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020893","descriptor_name":"Receptor, ErbB-3","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D020893","descriptor_name":"Receptor, ErbB-3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020893","descriptor_name":"Receptor, ErbB-3","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D034741","descriptor_name":"RNA, Small Interfering","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-08-2980","doi":"https://doi.org/10.1158/1078-0432.ccr-08-2980","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-08-2980","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:19706799","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19706799","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W79846600","https://openalex.org/W1486525671","https://openalex.org/W1512445277","https://openalex.org/W1527131381","https://openalex.org/W1537375311","https://openalex.org/W1619850371","https://openalex.org/W1925087632","https://openalex.org/W1967861333","https://openalex.org/W1970060716","https://openalex.org/W1970439470","https://openalex.org/W1971837077","https://openalex.org/W1983154518","https://openalex.org/W1987013884","https://openalex.org/W1996438825","https://openalex.org/W2004272510","https://openalex.org/W2005631145","https://openalex.org/W2007685062","https://openalex.org/W2019961689","https://openalex.org/W2023815439","https://openalex.org/W2027160550","https://openalex.org/W2028704745","https://openalex.org/W2030232704","https://openalex.org/W2036270511","https://openalex.org/W2036922484","https://openalex.org/W2042103473","https://openalex.org/W2045147990","https://openalex.org/W2050637252","https://openalex.org/W2074440232","https://openalex.org/W2086702949","https://openalex.org/W2094018486","https://openalex.org/W2098455835","https://openalex.org/W2099063182","https://openalex.org/W2100189272","https://openalex.org/W2112206631","https://openalex.org/W2119073457","https://openalex.org/W2120181506","https://openalex.org/W2126783165","https://openalex.org/W2141363880","https://openalex.org/W2143385760","https://openalex.org/W2144724291","https://openalex.org/W2167341806","https://openalex.org/W2171261313","https://openalex.org/W2171313739","https://openalex.org/W2181809628","https://openalex.org/W2581303447","https://openalex.org/W3139763557"],"related_works":["https://openalex.org/W2076627593","https://openalex.org/W2007685062","https://openalex.org/W2083806702","https://openalex.org/W2999635490","https://openalex.org/W4318044161","https://openalex.org/W2162031920","https://openalex.org/W2376444541","https://openalex.org/W2045147990","https://openalex.org/W2800547872","https://openalex.org/W4293328582"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1,61,139],"insulin-like":[2],"growth":[3,115],"factor":[4,116],"(IGF)":[5],"signaling":[6],"axis":[7],"is":[8],"frequently":[9],"dysregulated":[10],"in":[11,48,72,84,95,123,213,224,242],"hepatocellular":[12],"carcinoma":[13],"(HCC).":[14],"Therefore,":[15],"we":[16],"investigated":[17],"whether":[18],"the":[19,23,162,169,184],"specific":[20],"targeting":[21,237],"of":[22,44,52,64,80,86,91,97,136,141,150,153,167,172,177,186],"IGF":[24],"type":[25],"1":[26],"receptor":[27,117],"(IGF-1R)":[28],"might":[29],"represent":[30],"a":[31,65,147,221,233],"new":[32],"therapeutic":[33],"approach":[34],"for":[35,236,245],"this":[36],"tumor.":[37],"EXPERIMENTAL":[38],"DESIGN:":[39],"Total":[40],"and":[41,55,88,134,152,164,174,194,217,240],"phosphorylated":[42,163],"levels":[43,166],"IGF-1R":[45,81,92,208,241],"were":[46,128],"measured":[47],"21":[49],"paired":[50],"samples":[51],"human":[53,74],"HCCs":[54,87],"adjacent":[56],"nontumoral":[57],"livers":[58],"using":[59],"ELISA.":[60],"antineoplastic":[62],"potency":[63],"novel":[66],"anti-IGF-1R":[67,228],"antibody,":[68],"AVE1642,":[69],"was":[70,82,93,179],"examined":[71],"five":[73],"hepatoma":[75,205],"cell":[76,106,125,131,196],"lines.":[77],"RESULTS:":[78],"Overexpression":[79],"detected":[83],"33%":[85],"increased":[89,195],"activation":[90,212],"observed":[94],"52%":[96],"tumors.":[98],"AVE1642":[99,142,159],"alone":[100,160],"had":[101],"moderate":[102],"inhibitory":[103],"effects":[104,122],"on":[105],"viability.":[107],"However,":[108],"its":[109],"combination":[110,140],"with":[111,130,143,189],"gefitinib,":[112],"an":[113,214],"epidermal":[114],"(EGFR)":[118],"inhibitor,":[119],"induced":[120,146],"supra-additive":[121],"all":[124],"lines":[126],"that":[127,204,218],"associated":[129],"cycle":[132],"blockage":[133],"inhibition":[135,209],"AKT":[137,154,192],"phosphorylation.":[138,155],"rapamycin":[144],"also":[145],"synergistic":[148],"reduction":[149],"viability":[151],"Of":[156],"marked":[157],"interest,":[158],"up-regulated":[161],"total":[165],"HER3,":[168],"main":[170],"partner":[171],"EGFR,":[173],"AVE1642-induced":[175],"phosphorylation":[176,193],"HER3":[178,187,211,219],"prevented":[180],"by":[181],"gefitinib.":[182],"Moreover,":[183],"down-regulation":[185],"expression":[188],"siRNA":[190],"reduced":[191],"sensitivity":[197],"to":[198,227],"AVE1642.":[199],"CONCLUSIONS:":[200],"These":[201,230],"findings":[202],"indicate":[203],"cells":[206],"overcome":[207],"through":[210],"EGFR-dependent":[215],"mechanism,":[216],"represents":[220],"critical":[222],"mediator":[223],"acquired":[225],"resistance":[226],"therapy.":[229],"results":[231],"provide":[232],"strong":[234],"rational":[235],"simultaneously":[238],"EGFR":[239],"clinical":[243],"trials":[244],"HCC].":[246]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2144264656","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":16},{"year":2015,"cited_by_count":17},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":21},{"year":2012,"cited_by_count":21}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
